Literature DB >> 33074239

Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study.

Paloma Martín-Jiménez1, Mariana I Muñoz-García1, David Seoane1, Lucas Roca-Rodríguez1, Ana García-Reyne2, Antonio Lalueza2,3,4, Guillermo Maestro2, Dolores Folgueira3,5, Víctor A Blanco-Palmero1,4,6, Alejandro Herrero-San Martín1,4,6, Sara Llamas-Velasco1,4,6, David A Pérez-Martínez1,3,4,6, Marta González-Sánchez1,4,6, Alberto Villarejo-Galende1,3,4,6.   

Abstract

We analyzed the frequency of cognitive impairment (CI) in deceased COVID-19 patients at a tertiary hospital in Spain. Among the 477 adult cases who died after admission from March 1 to March 31, 2020, 281 had confirmed COVID-19. CI (21.1% dementia and 8.9% mild cognitive impairment) was a common comorbidity. Subjects with CI were older, tended to live in nursing homes, had shorter time from symptom onset to death, and were rarely admitted to the ICU, receiving palliative care more often. CI is a frequent comorbidity in deceased COVID-19 subjects and is associated with differences in care.

Entities:  

Keywords:  COVID-19; Cognitive impairment; dementia; morbidity; mortality

Year:  2020        PMID: 33074239     DOI: 10.3233/JAD-200937

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  14 in total

1.  The effects of Alzheimer's and Parkinson's disease on 28-day mortality of COVID-19.

Authors:  M Fathi; F Taghizadeh; H Mojtahedi; S Zargar Balaye Jame; N Markazi Moghaddam
Journal:  Rev Neurol (Paris)       Date:  2021-09-13       Impact factor: 4.313

Review 2.  COVID-19 and Alzheimer's disease: how one crisis worsens the other.

Authors:  Xiaohuan Xia; Yi Wang; Jialin Zheng
Journal:  Transl Neurodegener       Date:  2021-04-30       Impact factor: 8.014

3.  COVID-19 in adults with dementia: clinical features and risk factors of mortality-a clinical cohort study on 125 patients.

Authors:  Agathe Vrillon; Elsa Mhanna; Clément Aveneau; Manon Lebozec; Lina Grosset; Diane Nankam; Fernanda Albuquerque; Raphaelle Razou Feroldi; Barbara Maakaroun; Iana Pissareva; Dalenda Cherni Gherissi; Julien Azuar; Véronique François; Claire Hourrègue; Julien Dumurgier; Lisette Volpe-Gillot; Claire Paquet
Journal:  Alzheimers Res Ther       Date:  2021-04-10       Impact factor: 6.982

4.  Dementia as a mortality predictor among older adults with COVID-19: A systematic review and meta-analysis of observational study.

Authors:  Ita Daryanti Saragih; Ice Septriani Saragih; Sakti Oktaria Batubara; Chia-Ju Lin
Journal:  Geriatr Nurs       Date:  2021-03-14       Impact factor: 2.361

Review 5.  Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview.

Authors:  Anamika Gupta; Hezlin Marzook; Firdos Ahmad
Journal:  Clin Exp Med       Date:  2022-04-01       Impact factor: 5.057

Review 6.  Factors Associated for Mortality of Older People With COVID 19: A Systematic Review and Meta-analysis.

Authors:  H D W T Damayanthi; K I P Prabani; Ishanka Weerasekara
Journal:  Gerontol Geriatr Med       Date:  2021-12-01

Review 7.  Circadian disturbances, sleep difficulties and the COVID-19 pandemic.

Authors:  Mohammad Ali Salehinejad; Anita Azarkolah; Elham Ghanavati; Michael A Nitsche
Journal:  Sleep Med       Date:  2021-07-14       Impact factor: 4.842

8.  COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications.

Authors:  Rajkumar Singh Kalra; Jaspreet Kaur Dhanjal; Avtar Singh Meena; Vishal C Kalel; Surya Dahiya; Birbal Singh; Saikat Dewanjee; Ramesh Kandimalla
Journal:  Front Aging Neurosci       Date:  2021-06-03       Impact factor: 5.750

9.  SARS-CoV-2 (COVID-19) as a Predictor of Neuroinflammation and Neurodegeneration: Potential Treatment Strategies.

Authors:  M V Putilina; D V Grishin
Journal:  Neurosci Behav Physiol       Date:  2021-06-23

Review 10.  The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7).

Authors:  David Simons; Lion Shahab; Jamie Brown; Olga Perski
Journal:  Addiction       Date:  2020-11-17       Impact factor: 7.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.